Table 2.
Vulindlela N=364 n (% of age group with no history of testing) |
Soweto N=624 n (% of age group with no history of testing) |
|||||
---|---|---|---|---|---|---|
| ||||||
No Previous Testing History | Total | pa | No Previous Testing History | Total | pa | |
Males | 0.004 | <.001 | ||||
<20 | 48 (92) | 52 | 17 (81) | 21 | ||
20–24 | 36 (86) | 42 | 66 (73) | 90 | ||
25–29 | 15 (63) | 24 | 47 (57) | 83 | ||
30–34 | 7 (78) | 9 | 20 (48) | 42 | ||
35–39 | 7 (64) | 11 | 14 (36) | 39 | ||
40–44 | 4 (50) | 8 | 13 (39) | 33 | ||
45+ | 25 (89) | 28 | 43 (60) | 72 | ||
Total | 142 (82) | 174 | 220 (58) | 380 | ||
Females | 0.013 | <.001 | ||||
<20 | 71 (77) | 92 | 18 (69) | 26 | ||
20–24 | 17 (63) | 27 | 28 (42) | 66 | ||
25–29 | 6 (40) | 15 | 13 (31) | 42 | ||
30–34 | 6 (46) | 13 | 7 (18) | 39 | ||
35–39 | 6 (67) | 9 | 6 (25) | 24 | ||
40–44 | 8 (73) | 11 | 8 (53) | 15 | ||
45+ | 20 (87) | 23 | 19 (59) | 32 | ||
Total | 134 (71) | 190 | 99 (41) | 244 |
Chi-square tests of age and history of testing for males and females separately within each site.